
Bijan Ahvazi
Examiner (ID: 16926, Phone: (571)270-3449 , Office: P/1763 )
| Most Active Art Unit | 1763 |
| Art Unit(s) | 1763, 4171, 1761, 1796 |
| Total Applications | 1549 |
| Issued Applications | 974 |
| Pending Applications | 113 |
| Abandoned Applications | 482 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6547891
[patent_doc_number] => 20100016439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'OPHTHALMIC DEVICE HAVING THERAPEUTIC AGENT DELIVERY CAPABILITY AND METHOD OF FORMING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/505558
[patent_app_country] => US
[patent_app_date] => 2009-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8355
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12505558
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/505558 | Ophthalmic device having therapeutic agent delivery capability and method of forming same | Jul 19, 2009 | Issued |
Array
(
[id] => 6000567
[patent_doc_number] => 20110117031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'METHOD FOR TREATING HYPERSENSITIVE TEETH'
[patent_app_type] => utility
[patent_app_number] => 13/002782
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5305
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117031.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002782
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002782 | METHOD FOR TREATING HYPERSENSITIVE TEETH | Jul 15, 2009 | Abandoned |
Array
(
[id] => 6496573
[patent_doc_number] => 20100010082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'FORMULATIONS FOR TREATING EYE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/500399
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22460
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20100010082.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500399 | FORMULATIONS FOR TREATING EYE DISORDERS | Jul 8, 2009 | Abandoned |
Array
(
[id] => 6494534
[patent_doc_number] => 20100009953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'CYCLOSPORIN DERIVATIVES FOR TREATING OCULAR AND DERMAL DISEASES AND CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/499911
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4405
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009953.pdf
[firstpage_image] =>[orig_patent_app_number] => 12499911
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/499911 | Cyclosporin derivatives for treating ocular and dermal diseases and conditions | Jul 8, 2009 | Issued |
Array
(
[id] => 5465760
[patent_doc_number] => 20090325960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'METHOD FOR TREATING INFLAMMATORY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/492869
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 40401
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325960.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492869
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492869 | METHOD FOR TREATING INFLAMMATORY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | Jun 25, 2009 | Abandoned |
Array
(
[id] => 5465759
[patent_doc_number] => 20090325959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'METHOD FOR TREATING OPHTHALMIC DISEASES USING RHO KINASE INHIBITOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/492603
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 45703
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325959.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492603
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492603 | METHOD FOR TREATING OPHTHALMIC DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | Jun 25, 2009 | Abandoned |
Array
(
[id] => 8141095
[patent_doc_number] => 20120095097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'OPHTHALMIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/377867
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6789
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095097.pdf
[firstpage_image] =>[orig_patent_app_number] => 13377867
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/377867 | Ophthalmic composition | Jun 24, 2009 | Issued |
Array
(
[id] => 5459076
[patent_doc_number] => 20090259228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Methods for Preventing Posterior Capsular Opacification'
[patent_app_type] => utility
[patent_app_number] => 12/489247
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5055
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20090259228.pdf
[firstpage_image] =>[orig_patent_app_number] => 12489247
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/489247 | Methods for Preventing Posterior Capsular Opacification | Jun 21, 2009 | Abandoned |
Array
(
[id] => 6186638
[patent_doc_number] => 20110124682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING REBAMIPIDE'
[patent_app_type] => utility
[patent_app_number] => 12/999967
[patent_app_country] => US
[patent_app_date] => 2009-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6976
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124682.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999967
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999967 | PHARMACEUTICAL COMPOSITION COMPRISING REBAMIPIDE | Jun 17, 2009 | Abandoned |
Array
(
[id] => 5374877
[patent_doc_number] => 20090312438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Compositions and Methods for Attenuating the Formation of A2E in the Retinal Pigment Epithelium'
[patent_app_type] => utility
[patent_app_number] => 12/483411
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7859
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312438.pdf
[firstpage_image] =>[orig_patent_app_number] => 12483411
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/483411 | Compositions and Methods for Attenuating the Formation of A2E in the Retinal Pigment Epithelium | Jun 11, 2009 | Abandoned |
Array
(
[id] => 6033608
[patent_doc_number] => 20110082221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'IN SITU GELLING SYSTEMS AS SUSTAINED DELIVERY FOR FRONT OF EYE'
[patent_app_type] => utility
[patent_app_number] => 12/996436
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5562
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082221.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996436
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996436 | IN SITU GELLING SYSTEMS AS SUSTAINED DELIVERY FOR FRONT OF EYE | Jun 10, 2009 | Abandoned |
Array
(
[id] => 5464491
[patent_doc_number] => 20090324691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'METHODS AND OPHTHALMIC DEVICES USED IN THE TREATMENT OF OCULAR ALLERGIES'
[patent_app_type] => utility
[patent_app_number] => 12/482676
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3883
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324691.pdf
[firstpage_image] =>[orig_patent_app_number] => 12482676
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/482676 | METHODS AND OPHTHALMIC DEVICES USED IN THE TREATMENT OF OCULAR ALLERGIES | Jun 10, 2009 | Abandoned |
Array
(
[id] => 5398482
[patent_doc_number] => 20090318545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Mast cell inhibition in diseases of the retina and vitreous'
[patent_app_type] => utility
[patent_app_number] => 12/455958
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13643
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318545.pdf
[firstpage_image] =>[orig_patent_app_number] => 12455958
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/455958 | Mast cell inhibition in diseases of the retina and vitreous | Jun 8, 2009 | Issued |
Array
(
[id] => 11255756
[patent_doc_number] => 09480645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-01
[patent_title] => 'Omega-3 oil containing ophthalmic emulsions'
[patent_app_type] => utility
[patent_app_number] => 12/476579
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 11765
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12476579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476579 | Omega-3 oil containing ophthalmic emulsions | Jun 1, 2009 | Issued |
Array
(
[id] => 6392795
[patent_doc_number] => 20100303915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'THERAPEUTIC OPTHALMIC EMULSIONS'
[patent_app_type] => utility
[patent_app_number] => 12/476547
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11733
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303915.pdf
[firstpage_image] =>[orig_patent_app_number] => 12476547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476547 | THERAPEUTIC OPTHALMIC EMULSIONS | Jun 1, 2009 | Abandoned |
Array
(
[id] => 8257748
[patent_doc_number] => 08207226
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-06-26
[patent_title] => 'Use of FAAH antagonists for treating dry eye and ocular pain'
[patent_app_type] => utility
[patent_app_number] => 12/476515
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3563
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12476515
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476515 | Use of FAAH antagonists for treating dry eye and ocular pain | Jun 1, 2009 | Issued |
Array
(
[id] => 5368569
[patent_doc_number] => 20090306128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS CONTAINING A FLUOROQUINOLONE ANTIBIOTIC DRUG'
[patent_app_type] => utility
[patent_app_number] => 12/474307
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4235
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306128.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474307
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474307 | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug | May 28, 2009 | Issued |
Array
(
[id] => 6360254
[patent_doc_number] => 20100087486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'METHODS FOR USING TGF-B RECEPTOR INHIBITORS OR ACTIVIN-LIKE KINASE (ALK) 5 INHIBITORS A-83-01 AND SB-431542 TO TREAT EYE DISEASE AND WOUND HEALING CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/474370
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 2853
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087486.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474370 | METHODS FOR USING TGF-B RECEPTOR INHIBITORS OR ACTIVIN-LIKE KINASE (ALK) 5 INHIBITORS A-83-01 AND SB-431542 TO TREAT EYE DISEASE AND WOUND HEALING CONDITIONS | May 28, 2009 | Abandoned |
Array
(
[id] => 5304304
[patent_doc_number] => 20090298956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'SELF-PRESERVED EMULSIONS'
[patent_app_type] => utility
[patent_app_number] => 12/472880
[patent_app_country] => US
[patent_app_date] => 2009-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5960
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298956.pdf
[firstpage_image] =>[orig_patent_app_number] => 12472880
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/472880 | SELF-PRESERVED EMULSIONS | May 26, 2009 | Abandoned |
Array
(
[id] => 5367252
[patent_doc_number] => 20090304811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Pharmaceutical Formulations Comprising Stabilized Polysaccharides and Source of Hydrogen Peroxide'
[patent_app_type] => utility
[patent_app_number] => 12/468136
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11982
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304811.pdf
[firstpage_image] =>[orig_patent_app_number] => 12468136
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/468136 | Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide | May 18, 2009 | Issued |